STAT+: Pharmalittle: Cancer drug trial yields remission in every patient; Novartis data hacked by extortionists
In results called unprecedented, an experimental GSK treatment shrank locally advanced rectal cancer until it was undetectable in all 14 patients in a clinical trial.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was restful and invigorating, because that oh-so familiar routine
